Synthesis, characterization and anticancer activity of zinc sulfide nanoparticle using heterocyclic Zn (II) thiosemicarbazone complex as a single source
Authors:   Department of Chemistry, School of Sciences, ITM University, Gwalior (M.P.) India- 474005, Kothari R. 
Published: November 2024

The green synthesis of zinc sulphide nanoparticles (Zn S NPs) using Zn(II) complex as a single molecular precursor is gaining importance due to its simplicity, cost – effectiveness and pharmacologically active nature. Now – a- day’s nanobiotechnolgy is increasing at a fast rate due to its many possible applications in the biomedical and, pharmaceuticals fields. In this paper, we have reported the synthesis of Chalcogenide nanostructured pharmacologically active Zn S nanoparticles using Zn (II) Heterocyclic thiosemicarbazone Complex as a Single Source. Zn (II) complex was synthesized by the reaction between Schiff base ligand and Zinc acetate salt in 2:1 molar ratio. Thiosemicarbazone have a wide clinical antitumor spectrum with efficacy in various tumor types such as leukemia, pancreatic cancer, breast cancer, non- small cell lung cancer, cervical cancer, prostate cancer and bladder cancer. These compounds possessed significant antineoplastic activity when the carbonyl group attachment of the side chain was located at a position alpha to the heterocyclic nitrogen atom, whereas attachment of the side chain ꞵ or gamma to the heterocyclic nitrogen atom, resulted in inactive antitumor agents. In addition, replacement of the heterocyclic ring N with carbon also resulted in a biologically inactive compound suggesting that a conjugated N, N, S -tridentate donor set is essential for the biological activities of thiosemicarbazone ligands. In our study, for synthesis of Zn S nanoparticles, the synthesized Zn(II) complex of thiosemicarbazone ligand was treated with aqueous extract of Parmotrema perlatum flowers. The use of aqueous extract of Parmotrema perlatum flowers in the synthesis of ZnS particles plays a very important role in reducing reaction time, reducing minimum possibility of side reactions and conversion of metal complexes into its nanoparticles in a very less time. All synthesized compounds were characterized by various structural, morphological, electronic and vibrational spectroscopic techniques and also evaluate the pharmacological activities of compounds like antioxidant, anti-inflammatory and anticancer activities. The peaks at 3414.82 cm-1 in FT-IR spectra confirms the presence of –OH groups and other bioactive agents in the aqueous extract of Parmotrema perlatum flowers, which acts as a capping and stabilizing agents in the synthesis of Zn S nano particles. The effective results of anti-cancer activity of compounds showed that the ZnS nanoparticles shows good cytotoxic activity against human breast cancer cell lines (MCF-7) using MTT assay. In this study, normal human cell lines used as standard for comparison purpose. The CTC50 values of ZnS nanoparticles was found to be 49.375µg/ml respectively. Therefore, it could be concluded that this biogenic method is effective for synthesis of Zn S nanoparticles from Zn(II) complex with desirable properties for potential biomedical applications which can be consider as a good drug candidate for anti-cancer therapy